Skip to Main Content
About this Publication
Whole blood cryopreservation in epidemiological studies.
Pubmed ID
12433734 (View this publication on the PubMed website)
Cancer Epidemiol. Biomarkers Prev. 2002 Nov; Volume 11 (Issue 11): Pages 1496-8

Hayes RB, Smith CO, Huang WY, Read Y, Kopp WC


Standardized and cost-effective biological sample collection, processing, and storage procedures are needed in large-scale epidemiological studies to provide material for testing a broad range of etiological hypotheses. One component of sample collection in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial involves shipment of blood in acid-citrate-dextrose anticoagulant to a central processing laboratory, where 10% DMSO is added, and whole blood aliquots are cryopreserved. A single technician is able to routinely process 50-60 samples/day. Tests conducted to evaluate potential uses of cryopreserved whole blood showed successful EBV transformation (>90%, up to 20 months of storage). In addition, lymphocytes maintained good viability and stable T-cell:B-cell ratios, and T cells maintained the capacity to proliferate in response to solid phase anti-CD3/CD28 plus interleukin 2. Whole blood cryopreservation is a cost-effective approach to large-scale storage of viable cells in epidemiological studies.

Related CDAS Studies